Szilard Kiss - Jun 17, 2024 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role: Director
Signature: /s/ John Rakow, Attorney-in-Fact
Stock symbol: ADVM
Transactions as of: Jun 17, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/20/2024, 04:43 PM
Previous filing: Jun 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADVM	Stock Option (Right to Buy)	Award	$0	+21 K		$0.00	21 K	Jun 17, 2024	Common Stock	21 K	$7.32	Direct	F1

Explanation of Responses:

Id	Content
F1	1/3 of the total number of shares subject to the option will vest and become exercisable on each anniversary of June 17, 2024 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on each such vesting date.

Content

1/3 of the total number of shares subject to the option will vest and become exercisable on each anniversary of June 17, 2024 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on each such vesting date.